Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.2.1.31 extracted from

  • Kim, D.H.; Jin, Y.H.
    Intestinal bacterial beta-glucuronidase activity of patients with colon cancer (2001), Arch. Pharm. Res., 24, 564-567.
    View publication on PubMed
Search for more literature for 3.2.1.31

Application

Application Comment Organism
medicine the potent beta-glucuronidase activity caused by the glucuronic acid conjugates from xenobiotics and endogenous compounds is a prime factor in the etiology of colon cancer Escherichia coli

Inhibitors

Inhibitors Comment Organism Structure
S-saccharic acid 1,4-lactone inhibits enzyme in several patients with colon cancer in addition to the healthy controls Escherichia coli

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Escherichia coli the potent beta-glucuronidase activity caused by the glucuronic acid conjugates from xenobiotics and endogenous compounds is a prime factor in the etiology of colon cancer ?
-
 ?

Organism

Organism UniProt Comment Textmining
Escherichia coli
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
feces of patients with colon cancer and healthy controls Escherichia coli
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information the potent beta-glucuronidase activity caused by the glucuronic acid conjugates from xenobiotics and endogenous compounds is a prime factor in the etiology of colon cancer Escherichia coli ?
-
 ?